Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Declan G Murphy

Showing results (11-20 of 414) with videos related to

Pageof 42
Sort By:
European Urology|February 13, 2016
Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerDeclan G Murphy, Homayoun Zargar
The Lancet. Oncology|September 8, 2022
Treatment options for metastatic hormone-sensitive prostate cancerLouise Kostos, Declan G Murphy
International Journal of Radiation Oncology, Biology, Physics|September 26, 2024
PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate CancerDeclan G Murphy, Louise Emmett
BJU International|August 16, 2016
Randomised controlled trials in robotic surgeryProkar Dasgupta, Declan G Murphy
European Urology|September 15, 2014
Word of wisdom. Re: enzalutamide in metastatic prostate cancer before chemotherapyKen Chow, Declan G Murphy
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 5, 2013
No excuse not to report complications using standardized methodologyDeclan G Murphy, Marni Basto
European Urology|July 9, 2013
Robotic radical cystectomy with intracorporeal neobladder: ready for prime time?Declan G Murphy, Paul Anderson
Nature Reviews. Urology|September 23, 2015
Prostate cancer: Growth of AS in the USA signals reduction in overtreatmentDeclan G Murphy, Stacy Loeb
European Urology|July 16, 2018
Getting the Balance Right-The Benefits and Uncertainties of Focal Therapy for Significant Prostate CancerDeclan G Murphy, Derya Tilki
Journal of Robotic Surgery|September 16, 2016
High prostatic fascia release or standard nerve sparing? A viewpoint from the Royal Melbourne HospitalDeclan G Murphy, Anthony J Costello
Pageof 42

Showing results (11-20 of 414) with videos related to

Sort By:
Pageof 42
European Urology|February 13, 2016
Words of Wisdom. Re: Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate CancerDeclan G Murphy, Homayoun Zargar
The Lancet. Oncology|September 8, 2022
Treatment options for metastatic hormone-sensitive prostate cancerLouise Kostos, Declan G Murphy
International Journal of Radiation Oncology, Biology, Physics|September 26, 2024
PSMA PET Staging is Advised for All High-Risk Patients With Localized Prostate CancerDeclan G Murphy, Louise Emmett
BJU International|August 16, 2016
Randomised controlled trials in robotic surgeryProkar Dasgupta, Declan G Murphy
European Urology|September 15, 2014
Word of wisdom. Re: enzalutamide in metastatic prostate cancer before chemotherapyKen Chow, Declan G Murphy
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 5, 2013
No excuse not to report complications using standardized methodologyDeclan G Murphy, Marni Basto
European Urology|July 9, 2013
Robotic radical cystectomy with intracorporeal neobladder: ready for prime time?Declan G Murphy, Paul Anderson
Nature Reviews. Urology|September 23, 2015
Prostate cancer: Growth of AS in the USA signals reduction in overtreatmentDeclan G Murphy, Stacy Loeb
European Urology|July 16, 2018
Getting the Balance Right-The Benefits and Uncertainties of Focal Therapy for Significant Prostate CancerDeclan G Murphy, Derya Tilki
Journal of Robotic Surgery|September 16, 2016
High prostatic fascia release or standard nerve sparing? A viewpoint from the Royal Melbourne HospitalDeclan G Murphy, Anthony J Costello
Pageof 42